Literature DB >> 18998012

Peak expiratory flow rate variability in apparently healthy school children aged 10-15 years in Oredo, Nigeria.

Wilson O Osarogiagbon1, Michael O Ibadin, Osawaru S Oviawe.   

Abstract

OBJECTIVE: To study the peak expiratory flow rate variability (PEFRVar) in apparently healthy school children in Oredo, Nigeria.
METHODS: We carried out a cross-sectional study of 438 subjects (10-15 years), attending the public junior secondary schools, between March and November 2005. The study took place in the Oredo Local Government Area. The age and anthropometry were taken and PEFRVar was determined using values obtained at 6 AM, 2 PM, and 10 PM over a 14-day period, using a mini-Wright peak expiratory flow meter.
RESULTS: Peak expiratory flow rate variability (mean+/-SD) was 4.5+/-1.3% for all subjects (4.4+/-1.0% for males, and 4.6+/-1.6% for females). Females had higher PEFRVar. The upper limits of 95% CI were 7.1% for all subjects (6.4% for males, and 7.8% for females). The PEFRVar showed an inverse relationship with height, age, and weight. Regression equations for PEFR and PEFRVar were derived for age, height, and weight.
CONCLUSION: Based on upper limit of 95% CI for all subjects, a PEFRVar cut-off of 7.1% is recommended for diagnosis of significant airway obstruction as in asthma in the age bracket under review in Oredo and perhaps other areas, sharing similar geo-physical and social characteristics.

Entities:  

Mesh:

Year:  2008        PMID: 18998012

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  2 in total

1.  Asthma management by medical practitioners: the situation in a developing country.

Authors:  Osarogiagbon Wilson Osaretin; Nwaneri Damian Uchechukwu; Oviawe Osawaru
Journal:  World J Pediatr       Date:  2012-12-29       Impact factor: 2.764

2.  Comparison between Emergency Severity Index plus peak flow meter and Emergency Severity Index in the dyspneic patients with chronic obstructive pulmonary disease: A randomized clinical trial.

Authors:  Mahin Hamechizfahm Roudi; Javad Malekzadeh; Mohsen Ebrahimi; Amir Mirhaghi; MohammadTaghi Shakeri
Journal:  Turk J Emerg Med       Date:  2019-04-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.